Neogenomics target price raised to $22 from $19
NEO•Needham raised its target price for Neogenomics to $22 from $19.
Related News
Locafy enters deal to buy Map Labs assets for up to US$3 million
LCFY•
Telomir Pharmaceuticals prices $5.6 million PIPE at $1.16 per share
TELO•
Humana report pegs Kentucky economic output impact at $19.9 billion in 2025
HUM•
Conagra Brands showcases snacks portfolio at NACS Show
CAG•
Standard Nuclear initiates coverage with buy rating; price target $18
STDN•